David Kaysen Email & Phone Number

Minneapolis, Mn, Us

SubioMed, Inc. is a commercial stage orthotic device company commercializing our patented foot and ankle Suspension Biomechanics technology which thoughtfully improves gait and manages Ground Reaction Force (GRF) with dynamic energy management and can optimize movement with precision motion control when needed.Our flagship product, Dynamic Suspension Orthotics (DSO) is a three layer, carbon fiber mechanical device inserted into footwear to provide the dynamic energy management and precision motion control.The DSO corrects and controls motion, targeting the hindfoot, midfoot and forefoot independently to optimize the gait cycle and reduce foot, ankle and other joint pain.

Plymouth, Mn, Us

InterRad Medical is committed to the development and commercialization of innovative medical devices for the use in minimally invasive interventional and surgical procedures.

Minneapolis, Minnesota, Us

EXB Solutions mission is to help our clients accelerate product development by improving requirements and automating development and test.

Madison, Wi, Us

Atrility Medical is a privately-held, commercial stage medical device company focused on cardiac health and improving the lives of patients through advances in medical technology. The company's first commercial product, the AtriAmp, facilitates monitoring and treatment of atrial arrhythmias in adult and pediatric heart patients by providing a continuous atrial electrogram.

Oranmore, Galway, Ie

Atlantic Therapeutics develops professional and consumer medical devices, related software, apps and connected health technologies to treat all types of incontinence, sexual health dysfunction, and other associated disorders by strengthening muscles and modulating nerves of the pelvic floor.

Spinal Singularity is a medical device company, developing products to improve the quality of life for individuals with spinal cord injuries and disease.

South Melbourne, Victoria, Au

Medibio is a mental health technology company leveraging objective digital biomarkers for products and services that assist in screening, diagnosing, monitoring, and managing of depression and other mental health conditions.

South Melbourne, Victoria, Au

A US publicly traded (OTCQB) pre-revenue clinical stage biopharmaceutical company focused on developing disruptive therapeutics for the treatment of pancreatic disease with initial focus on pancreatic cancer and pancreatitis.

Darien, Connecticut, Us

Privately held Belgium based world-wide developer, manufacturer and marketer of external neuromodulation devices to treat the cranial space targeting solving the global problem of migraine and other headache disorders.

Us

As the CEO of Uroplasty, I led the growth of this publicly traded world-wide manufacturer and marketer of devices for office based treatment of voiding dysfunctions, specifically incontinence and overactive bladder, selling primarily to Urologist, Uro-gynecologists and Gynecologists, from $6 to $23M.

Brought on as CEO to integrate tuck on acquisitions for this private equity owned replicator and duplicator of CD, CD-ROM, DVD and DVD-ROM discs, including all artwork, printing, packaging and fulfillment for a diverse customer base.

Recruited by the Board of Directors and hired as the CEO, of this publicly traded manufacturer and world-wide marketer of critical care blood and tissue analysis systems, which provided immediate and continuous diagnostic results at the point-of-patient and in acute, critical care environments.